Special Issue “The Promising Future of CAR-Based Therapies: A Matter of Molecular Details”
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26199587 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Fabio Nicolini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 40121 Meldola, Italy. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Neoplasms, Hematologic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In the rapidly advancing field of cancer immunotherapy, Chimeric Antigen Receptor (CAR)-T cell therapy is redefining treatment paradigms and offering renewed hope to patients with hematologic malignancies [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Advanced Cellular Therapies and Rare Tumors Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 40121 Meldola, Italy.
- Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
ORCID-Profile: Fabio Nicolini, Orsola Montini, Matteo Zurlo, Massimiliano Mazza
Zitieren
APA
Nicolini, F., Montini, O., Zurlo, M., Tettamanti, S., & Mazza, M. (2025). Special Issue “The Promising Future of CAR-Based Therapies: A Matter of Molecular Details”. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199587
Vancouver
Nicolini F, Montini O, Zurlo M, Tettamanti S, Mazza M. Special Issue “The Promising Future of CAR-Based Therapies: A Matter of Molecular Details”. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199587
BibTeX
@article{Nicolini2025,
author = {Nicolini, Fabio and Montini, Orsola and Zurlo, Matteo and Tettamanti, Sarah and Mazza, Massimiliano},
title = {Special Issue “The Promising Future of CAR-Based Therapies: A Matter of Molecular Details”},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26199587}
}
EUVIMED